KA63.1ICD-11 MMS 2026-01
Neonatal aspergillosis
Description
A disease affecting neonates, caused by an infection with the fungi Aspergillus. This disease presents with clinical symptoms depending on the site of infection. Transmission is by inhalation of Aspergillus spores, or direct contact. Confirmation is by identification of Aspergillus from affected sites.
Coding note from above levels
Conditions arising in the perinatal period, even though death or morbidity occurs later, should, as far as possible, be coded to chapter 19, which takes precedence over chapters containing codes for diseases by their anatomical site. For children less than 28 days old, assume that a reported condition developed in the perinatal period, unless the duration is stated and the onset was after the first completed week of life.
Index terms
- Neonatal aspergillosis
Exclusions from above levels
1C62.0– Asymptomatic human immunodeficiency virus infection- http://id.who.int/icd/entity/1000704511 – human immunodeficiency virus [HIV] disease
- http://id.who.int/icd/entity/588616678 – Gastroenteritis or colitis of infectious origin
Show allHide
- http://id.who.int/icd/entity/609214049 – congenital gonococcal infection
MA14.0– Laboratory evidence of human immunodeficiency virus01– Certain infectious or parasitic diseases - acquired after birth02– Neoplasms05– Endocrine, nutritional or metabolic diseases08– Certain congenital diseases of the nervous system20– Congenital malformations, deformations and chromosomal abnormalities22– Injury, poisoning or certain other consequences of external causes3A10– Hereditary haemolytic anaemia4A01.03– Transient hypogammaglobulinaemia of infancy9B71.3– Retinopathy of prematurityBC43– congenital cardiomyopathyDA93.0– Paralytic ileusEA50.Z– Pemphigus neonatorumEH40.00– Cradle cap
Sibling codes
Foundation entity
Neonatal aspergillosis – http://id.who.int/icd/entity/1791817517
Part of: KA63: Fungal infection of fetus or newborn › 19: Certain conditions originating in the perinatal period